MedPath

SULINDAC

SULINDAC TABLETS USP

Approved
Approval ID

6db52fd3-172f-47ab-8aa6-4f3d031c6b25

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 27, 2021

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sulindac

PRODUCT DETAILS

NDC Product Code71335-0413
Application NumberANDA072051
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 27, 2022
Generic Namesulindac

INGREDIENTS (4)

SULINDACActive
Quantity: 200 mg in 1 1
Code: 184SNS8VUH
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SULINDAC - FDA Drug Approval Details